Grandlife Medical And Pharma Research Ll P Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 23-01-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 41.16 Cr
as on 23-01-2024
- Revenue -85.62%
(FY 2021)
- Profit -108.41%
(FY 2021)
- Ebitda -77.47%
(FY 2021)
- Total Assets -22.93%
(FY 2021)
About Grandlife Medical And Pharma Research Ll P
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAK-4070
- Incorporation Date
25 Aug 2017
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Jaipur
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Grandlife Medical And Pharma Research Ll P?
Designated Partners(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumeet Agarwal  | Designated Partner | 25-Aug-2017 | Current |
| Babu Jangir | Designated Partner | 25-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Grandlife Medical And Pharma Research Ll P.
Grandlife Medical And Pharma Research Ll P, for the financial year ended 2021, experienced significant reduction in revenue, with a 85.62% decrease. The company also saw a substantial fall in profitability, with a 108.41% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grandlife Medical And Pharma Research Ll P?
Unlock access to Grandlife Medical And Pharma Research Ll P's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Jai Govind Devji Agro Farming Developers Private LimitedActive 12 years 11 months
Sumeet Agarwal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 May 2021 | ₹20.58 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Jul 2019 | ₹20.58 Cr | Open |
How Many Employees Work at Grandlife Medical And Pharma Research Ll P?
Grandlife Medical And Pharma Research Ll P has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grandlife Medical And Pharma Research Ll P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandlife Medical And Pharma Research Ll P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
